<DOC>
	<DOCNO>NCT00691613</DOCNO>
	<brief_summary>Rationale : The investigator hypothesize EPO protect apoptosis acute ischemia man detectable use annexin-A5 model . Objective : Does infusion single dose Epoetin Alfa , short-acting EPO , protect apoptosis man acute ischemia ? Study design : A double blind randomise cross-over study . Study population : 12 Healthy male volunteer , 18 40 year old . Intervention : All 12 volunteer receive single dose EPO placebo randomize order . A six week wash-out period obtain order avoid interference treatment . Main study parameters/endpoints : The percentage difference radioactivity ( quantified count per pixel ) experimental control thenar muscle one four hour reperfusion .</brief_summary>
	<brief_title>Infusion Single Dose Erythropoietin Prevent Injury Ischemia Reperfusion Forearm Model</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Healthy volunteer 18 40 year age male Volunteers allow smoke 24 hour start experiment Female Hypertension ( SBP &gt; 140 mmHg , DBP &gt; 90 mmHg ) Diabetes Mellitus ( DM ) ( fast glc &gt; 6.9 mmol/l , glc &gt; 11.0 mmol/l ) Hypercholesterolemia Renal dysfunction ( eGFR &lt; 60 ml/min , calculate use MDRD formula ) Any know hypersensitivity/allergic reaction one constituents Epoetin Alfa A history use form EPO Any current medication use Cardiovascular disease medical history Smoking le 24 hour prior Epoetin alpha infusion Participation research last 5 year form radioactivity use No participation research trial last 30 day 5 time halflife use substance</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Apoptosis</keyword>
	<keyword>Annexin</keyword>
	<keyword>Hypoxia</keyword>
	<keyword>Ischemia-Reperfusion Injury</keyword>
</DOC>